FDA panel backs Merck insomnia drug, but warns of safety concerns 24 May 2013 / By Tim / Drug Safety, Featured on app / 0 comments
Increasing struggles in cell therapies manufacturing as production ramps up 9 May 2013 / By andre / Antibodies, Cell Culture, Clinical Trials, Manufacturing, Regenerative Medicine, Supply Chain & Manufacturing / 0 comments
Top 5 Most Surprising Pharma Regulatory Agency Rejections 29 April 2013 / By Tim / Drug Safety, Featured on app, Regulation and Government / 0 comments
Johnson & Johnson’s first-of-a-kind diabetes drug Invokana gets the FDA green light 3 April 2013 / By Tim / Featured on app, Regulation and Government / 0 comments
First US state introduces biosimilars law 27 March 2013 / By Tim / Featured on app, Regulation and Government / 0 comments
Why orphan drugs are a key part of pharma’s future? 30 November 2012 / By andre / Clinical Trials, Drug Discovery, Manufacturing, Market Access, Orphan Drugs, Partnering & Investment, Regulation and Government / 0 comments
Is drug repositioning surpassing new brands discovery and development? 25 October 2012 / By andre / Clinical Trials, Drug Discovery, Drug Safety, Manufacturing, Orphan Drugs, Partnering & Investment, Regulation and Government, Reports / 0 comments
AFBF vs FDA – who’s right? 14 September 2012 / By Laura Lupo / Drug Safety, Regulation and Government / 0 comments
Download: Survey report on antibiotics use in production animals 10 September 2012 / By Laura Lupo / Drug Safety, Featured on app / 2 comments
Have 2 minutes for our survey on the FDA antibiotics debate? 17 August 2012 / By Laura Lupo / Drug Safety / 0 comments
